Shocking vaccine gaps in liver patients revealed!
NCT ID NCT04939350
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This study looked at 742 adults with cirrhosis (serious liver scarring) in French general hospitals to see how many got recommended vaccines for hepatitis A and B, flu, COVID-19, pneumonia, and tetanus/diphtheria/polio. The goal was to find gaps in protection, not to test a new treatment. Results will help doctors improve vaccination rates in this vulnerable group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, 91106, France
Conditions
Explore the condition pages connected to this study.